GL Capital Group has been investing in healthcare and healthcare only for 15 years, managing nearly USD 3.4 billion in healthcare assets. The firm has invested in 99 companies across diverse healthcare sub-sectors, such as pharmaceuticals, medical enterprises, healthcare services, in-vitro diagnostics (lVD), and contract research organizations (CROs), spanning the entire healthcare value chain, GL Capital partners with its portfolio companies to navigate challenges and seize opportunities in a continuously evolving industry and market, driving growth and value creation